Baird's CMC | Sexual and Reproductive Health

Sexual and Reproductive Health

Tel: +44 (0) 1495 200096
Email: team@bairdscmc.com
  • E-mail
  • LinkedIn
  • Twitter
Menu
  • Baird’s CMC Home
  • SRH Home
  • Why Us
    • Why work with Baird’s CMC in Sexual and Reproductive Health?
    • Affordable Pricing
    • Our Clients
    • Global database of SRH civil society organizations
    • Close
  • What we do
    • Qualitative Research
    • Policy Research & Analysis
    • Stakeholder Mapping
    • Assessing Opportunities & Demand Forecasting
    • Developing Organisational Strategy
    • Communications Strategy
    • Product Launches
    • Policy Communication
    • Government Relations
    • Issues Management
    • Scientific Communications
    • Public Relations
    • Close
  • Expertise
    • Hepatitis C
    • HIV / AIDS
    • Vaccines
    • Family Planning
    • Close
  • Our Team
    • Eric Brown, San Francisco, USA
    • Mark Chataway, Wales, UK
    • Lenore Cooney, New York, USA
    • Gerard Cunningham, Pennsylvania, USA
    • Paul Dillon, Dublin, Ireland
    • Marta Dourado, São Paulo, Brazil
    • Martina Dörmann, Berlin, Germany
    • Dirk van Eeden, Chicago, USA
    • Aman Gupta, New Delhi, India
    • Angelle B. Kwemo, USA
    • Simba Makoni, Harare, Zimbabwe
    • Terry Mandel, San Francisco, California, USA
    • Matshidiso Masire, Botswana
    • Valeria McFarren Piper, Charlottesville, USA
    • Hugh McKinney, London, UK
    • Dr. Ken Rabin, Warsaw, Poland
    • James Snodgrass, London, UK
    • Hema Viswanathan, Mumbai, India
    • Mina Volovitch, Paris, France
    • Chris Ward, Ontario, Canada
    • Marion Zibelli, Barcelona, Spain
    • Close
  • Case Studies
  • Blog
  • Get in Touch
You are here: Home / What we do / Policy Research & Analysis

Policy Research & Analysis

Our experience

Some of the co-owners of Baird’s CMC have worked on policy issues in HIV since the early 1980s, on family planning since the 1970s and on women’s health issues over the same forty-year period.

Several now serve on boards of major international donors and implementers. Our partners have similarly impressive experience from work in foundations, governments and pharmaceutical companies.

That makes us uniquely well-positioned to tackle the toughest and most subtle policy issues.

What we’ve done

  • A 47-country study of health and research priorities in sub-Saharan Africa for the European and Developing Country Clinical Trials Partnership, an agency of the European Commission. One of the focus areas was HIV
  • A study on likely future policy on HPV vaccination in India for a major vaccine developer
  • Two rounds of work for the Johns Hopkins Bloomberg School of Public Health on the reasons why vaccines — including hepatitis B — have or have not been adopted in low-income countries
  • Identification of the 200 most influential people in the world on HIV policy, how they interacted and which led which areas of discussion. The project included organising independent expert review and validation of our findings
  • In-depth research for Gavi on the opportunities for new donor funding from the BRICS countries and the Middle East. One of the Gavi initiatives discussed was immunisation against HPV and the prevention of cervical cancer
  • A project for the Department of Science and Technology of the Republic of South Africa on the future of the country’s HIV vaccine research programme
  • A continuing project on India’s likely approach to access to medicines and to purchasing, pricing and intellectual property. We also look at interactions with civil society. Clients for this work have included PhRMA, major pharmaceutical companies and NGOs

Among our co-owners, Baird’s CMC counts several former ministers and leaders of multilaterals organisations.

Among our partners are chairs of large international NGOs and former senior multilateral officials.

We actually understand the complexity of how policy is made in different types of countries and at international level.

Copyright © 2023 All rights reserved. Sitemap